Verily

Verily, an Alphabet company, is building the future of precision health through an AI-native platform designed to transform complex health data into actionable insights for research, care, and improved patient outcomes. Serving researchers, clinicians, health systems, and consumers alike, Verily's mission is to bring the promise of precision health to everyone, every day.

At the core of Verily's offering is Verily Pre, the company's AI-native platform for precision health. Pre serves as the foundational infrastructure enabling researchers, sponsors, and health organizations to discover, analyze, and act on diverse biomedical datasets. The platform has gained "awardable" status on the Tradewinds Solutions Marketplace, streamlining procurement for federal agencies seeking to leverage its capabilities.

Key Products and Modules

• Verily Pre Platform: The flagship AI-native platform that accelerates the development of AI agents and models across research and care settings, with GPU-powered tools available through a collaboration with NVIDIA.
• Verily Exchange: A module on the Pre platform that lowers the barrier for researchers to discover diverse biomedical datasets; a free version is now available.
• Verily Workbench: An analytical environment on the Pre platform enabling researchers to analyze complex datasets; also available in a free version to broaden access.
• Verily Refinery: A precision data tool built on Pre, designed to overcome low-resolution data bottlenecks and unlock the unseen value of high-quality health data.
• Verily Me: A consumer-facing health app officially available for U.S. consumers, providing personalized health recommendations from licensed clinicians, closing gaps in care, and offering a private space for individuals to make sense of their health. The app was announced at SXSW 2026 and launched at HLTH USA 2025.
• Lifelong Health Study: A Verily-sponsored research registry designed to continuously follow participants on their health journeys, creating a more complete and realistic picture of human health.

Core Capabilities

• AI-native data transformation for precision health research and clinical care
• Discovery and analysis of diverse biomedical datasets through Exchange and Workbench
• High-resolution precision data processing via Verily Refinery
• Development and deployment of AI agents and models for research and care workflows
• Personalized health recommendations delivered directly to consumers through Verily Me
• Support for longitudinal health research through the Lifelong Health Study registry
• Acceleration of clinical research through bundled solutions for study sponsors

Notable Partnerships, Funding, and Integrations

• Raised $300 million in new funding led by Series X Capital, with participation from Alphabet, UCHealth, and the University of Colorado Anschutz, to accelerate its precision health AI strategy.
• Strategic multi-year collaboration with UCHealth, the University of Colorado Anschutz, and RefinedScience to transform how data is used and care is delivered.
• Collaboration with NVIDIA to speed the development of AI agents and models, with the NVIDIA AI stack now available for researchers on Verily Pre.
• Collaboration with Samsung, announced at HIMSS26, delivering a bundled solution that unlocks advanced insights for clinical study sponsors.
• Led a consortium that secured a $9.2 million NIH award extension to advance FAIRplex and power AMP® data analysis.
• Federal accessibility established through "awardable" status on the Tradewinds Solutions Marketplace.
• Transitioning to operate as an independent company under the leadership of CEO Stephen Gillett, marking a new chapter as Verily Health.

With a growing platform ecosystem, significant institutional backing, and deep partnerships across industry and academia, Verily is positioned as a comprehensive precision health AI company serving the full spectrum from large-scale biomedical research to individual consumer health management.